​

Amgen (AMGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AMGN Stock Forecast

Amgen (AMGN) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $364.09, with a high of $425.00 and a low of $309.00. This represents a -1.01% decline from the last price of $367.80.

$250 $290 $330 $370 $410 $450 High: $425 Avg: $364.09 Low: $309 Last Closed Price: $367.8

AMGN Stock Rating

Amgen stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 22 Buy (61.11%), 11 Hold (30.56%), 3 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 36 3 11 22 0 Strong Sell Sell Hold Buy Strong Buy

AMGN Price Target Upside V Benchmarks

TypeNameUpside
StockAmgen-1.01%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks-2.97%

Price Target Trends

1M3M12M
# Anlaysts61218
Avg Price Target$362.33$364.50$346.94
Last Closing Price$367.80$367.80$367.80
Upside/Downside-1.49%-0.90%-5.67%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26410152132
Jan, 26410152132
Dec, 25410152132
Nov, 25310152131
Oct, 25310152131
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 04, 2026RBC Capital$360.00$357.290.76%-2.12%
Feb 04, 2026Morgan Stanley$309.00$351.81-12.17%-15.99%
Jan 29, 2026Oppenheimer$400.00$343.5716.42%8.75%
Jan 26, 2026UBS$390.00$348.9911.75%6.04%
Jan 20, 2026Market PerformBernstein$335.00$330.441.38%-8.92%
Jan 06, 2026UBS$380.00$330.1715.09%3.32%
Dec 12, 2025Morgan Stanley$304.00$317.67-4.30%-17.35%
Dec 10, 2025HSBC$425.00$313.8535.42%15.55%
Dec 03, 2025Evan SeigermanBMO Capital$372.00$338.369.94%1.14%
Nov 25, 2025Wells Fargo$400.00$334.3019.65%8.75%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 04, 2026Bank of America SecuritiesUnderperformUnderperformhold
Feb 04, 2026Cantor FitzgeraldNeutralNeutralhold
Feb 04, 2026RBC CapitalOutperformOutperformhold
Feb 04, 2026Cowen & Co.BuyBuyhold
Feb 04, 2026CitigroupNeutralNeutralhold
Jan 29, 2026OppenheimerOutperformOutperformhold
Jan 26, 2026UBSBuyBuyhold
Jan 20, 2026BernsteinOutperformMarket Performdowngrade
Jan 06, 2026UBSNeutralBuyupgrade
Dec 17, 2025OppenheimerOutperformPositiveupgrade

Financial Forecast

EPS Forecast

$5 $11 $17 $23 $29 $35 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.34$12.18$12.56$7.56----
Avg Forecast$16.82$17.68$18.56$19.59$21.01$21.45$22.22$22.74
High Forecast$17.52$18.41$18.98$19.86$22.39$30.68$31.07$23.91
Low Forecast$16.19$16.80$18.23$19.25$19.62$10.68$16.86$21.04
Surprise %-38.53%-31.11%-32.33%-61.41%----

Revenue Forecast

$25B $28B $31B $34B $37B $40B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$25.98B$26.32B$28.19B$33.42B----
Avg Forecast$26.00B$26.17B$28.12B$33.20B$34.61B$35.07B$35.60B$36.33B
High Forecast$26.84B$27.00B$28.29B$33.48B$35.96B$35.08B$35.66B$37.75B
Low Forecast$25.25B$25.17B$27.97B$32.91B$32.45B$35.06B$35.55B$34.23B
Surprise %-0.09%0.58%0.26%0.68%----

Net Income Forecast

$0 $4B $8B $12B $16B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.89B$6.55B$6.72B$4.09B----
Avg Forecast$5.71B$6.49B$6.72B$10.52B$11.30B$7.13B$12.89B$12.24B
High Forecast$6.85B$7.79B$8.06B$10.68B$12.05B$16.50B$16.71B$12.86B
Low Forecast$4.56B$5.19B$5.37B$10.36B$10.56B$5.74B$9.07B$11.32B
Surprise %3.29%0.90%--61.12%----

AMGN Forecast FAQ

Is Amgen stock a buy?

Amgen stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 22 Buy, 11 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Amgen is a favorable investment for most analysts.

What is Amgen's price target?

Amgen's price target, set by 36 Wall Street analysts, averages $364.09 over the next 12 months. The price target range spans from $309 at the low end to $425 at the high end, suggesting a potential -1.01% change from the previous closing price of $367.8.

How does Amgen stock forecast compare to its benchmarks?

Amgen's stock forecast shows a -1.01% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (-2.97%).

What is the breakdown of analyst ratings for Amgen over the past three months?

  • February 2026: 12.50% Strong Buy, 31.25% Buy, 46.88% Hold, 6.25% Sell, 3.12% Strong Sell.
  • January 2026: 12.50% Strong Buy, 31.25% Buy, 46.88% Hold, 6.25% Sell, 3.12% Strong Sell.
  • December 2025: 12.50% Strong Buy, 31.25% Buy, 46.88% Hold, 6.25% Sell, 3.12% Strong Sell.

What is Amgen’s EPS forecast?

Amgen's average annual EPS forecast for its fiscal year ending in December 2025 is $21.01, marking a 177.91% increase from the reported $7.56 in 2024. Estimates for the following years are $21.45 in 2026, $22.22 in 2027, and $22.74 in 2028.

What is Amgen’s revenue forecast?

Amgen's average annual revenue forecast for its fiscal year ending in December 2025 is $34.61B, reflecting a 3.55% increase from the reported $33.42B in 2024. The forecast for 2026 is $35.07B, followed by $35.6B for 2027, and $36.33B for 2028.

What is Amgen’s net income forecast?

Amgen's net income forecast for the fiscal year ending in December 2025 stands at $11.3B, representing an 176.33% increase from the reported $4.09B in 2024. Projections indicate $7.13B in 2026, $12.89B in 2027, and $12.24B in 2028.